Who Exports Sorafenib from India — 203 Suppliers Behind a $16.6M Market
India's sorafenib export market is supplied by 203 active exporters who collectively shipped $16.6M across 916 shipments. TORRENT PHARMACEUTICALS LTD leads with a 19.1% market share, followed by NATCO PHARMA LIMITED and MEDYRA PHARMACEUTICAL. The top 5 suppliers together control 30.4% of total export value, reflecting a moderately competitive market structure.
Top Sorafenib Exporters from India — Ranked by Export Value
TORRENT PHARMACEUTICALS LTD is the leading sorafenib exporter from India, holding a 19.1% share of the $16.6M market across 916 shipments from 203 exporters. The top 5 suppliers — TORRENT PHARMACEUTICALS LTD, NATCO PHARMA LIMITED, MEDYRA PHARMACEUTICAL, HEET HEALTHCARE PRIVATE LIMITED, JODAS EXPOIM PRIVATE LIMITED — collectively control 30.4% of total export value, indicating a competitive market. Individual shares are: TORRENT PHARMACEUTICALS LTD (19.1%), NATCO PHARMA LIMITED (9.5%), MEDYRA PHARMACEUTICAL (1.0%), HEET HEALTHCARE PRIVATE LIMITED (0.5%), JODAS EXPOIM PRIVATE LIMITED (0.4%).
Top Sorafenib Exporters from India
Ranked by export value · 203 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD SORAFENIB TABLETS 200MG 120S HDPE USSORAFENIB TABLETS USP 200MG, 120S HDPE, US )SORAFENIB TABLETS USP 200MG 120S HDPE US | $3.2M | 2 | 19.1% |
| 2 | NATCO PHARMA LIMITED SORAFENIB 200MG TABLETSSORAFENAT 200MG TABLETS 60'S(SORAFENIB TSORAFENIB TABLETS IP 200 MG 1*120 BOTTLE | $1.6M | 4 | 9.5% |
| 3 | MEDYRA PHARMACEUTICAL SORAFYRA-200 SORAFENIB 200MG TABLETSSORAFENAT 200MG TABLETS 60'S(SORAFENIB TSORAFENIB TABLETS IP 200 MG 1*120 BOTTLE | $162.4K | 4 | 1.0% |
| 4 | HEET HEALTHCARE PRIVATE LIMITED SORAFENIB TABLETS IP 200MG OTHER DETAILSAS PER INVOICENOS | $76.4K | 9 | 0.5% |
| 5 | JODAS EXPOIM PRIVATE LIMITED SORAFENIB TABLETS 200MG TBSSORAFENIB TABLETS 200 MG EACH COATED TABSORAFENIB TABLETS 200MG | $66.5K | 1 | 0.4% |
| 6 | CIPLA LIMITED | $65.8K | 1 | 0.4% |
| 7 | PROSPERA LIFE SCIENCES PRIVATE LIMITED SORAFENAT 200MG TABLETS 60'S(SORAFENIB TSORAFENIB TABLETS IP 200 MG 1*120 BOTTLE | $62.8K | 4 | 0.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Sorafenib exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Torrent Pharmaceuticals Limited | Warning Letter (October 2 | Yes (Date not specif | Yes | Not verified | Received FDA Warning Letter in October 2019 for CGMP violations at Indrad facili |
| Cipla Limited | Approved | Yes (Date not specif | Yes | Not verified | Cipla's manufacturing facilities are approved by FDA, WHO-GMP, and EU GMP. |
| Natco Pharma Limited | Approved | Yes (Date not specif | Yes | Not verified | Natco's facilities have FDA, WHO-GMP, and EU GMP approvals. |
| Jodas Expoim Private Limited | Approved | Yes (Date not specif | Yes | Not verified | Jodas Expoim's facilities are certified by FDA, WHO-GMP, and EU GMP. |
| Medyra Pharmaceutical | Not Listed | Yes (Date not specif | No | Not verified | Medyra Pharmaceutical holds WHO-GMP certification but lacks FDA and EU GMP appro |
| Heet Healthcare Private Limited | Not Listed | Yes (Date not specif | No | Not verified | Heet Healthcare has WHO-GMP certification but does not have FDA or EU GMP approv |
| Prospera Life Sciences Private Limited | Not Listed | Yes (Date not specif | No | Not verified | Prospera Life Sciences holds WHO-GMP certification but lacks FDA and EU GMP appr |
TransData Nexus reviewed the regulatory standing of 7 leading Sorafenib exporters from India. 3 hold US FDA facility approvals, 7 maintain WHO-GMP certification, and 4 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Sorafenib sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the nation's bulk drug production. The city hosts numerous pharmaceutical companies specializing in Active Pharmaceutical Ingredients (APIs) and bulk drugs. For instance, SVK Laboratories, established in 2007, focuses on manufacturing high-quality bulk drugs and drug intermediates at its state-of-the-art facility in Jeedimetla, Hyderabad. Similarly, Vasudha Pharma Chem Ltd., located in Jeedimetla, is known for producing bulk drugs and intermediates. This concentration of bulk drug manufacturers positions Hyderabad as a strategic location for sourcing APIs like Sorafenib.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Companies such as Alembic Pharmaceuticals, headquartered in Vadodara, have a significant presence in this region. Additionally, Mercury Laboratories Limited, based in Vadodara, has been a leading pharmaceutical manufacturer for over five decades, offering a diverse product portfolio across multiple therapeutic segments. This region's focus on formulations makes it a key area for sourcing finished pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. This region's well-developed infrastructure and proximity to major ports facilitate efficient export operations. Many pharmaceutical companies have established their export-oriented units here to leverage these logistical advantages.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, primarily due to favorable tax incentives offered by the government. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units in the area, contributing to its rapid industrial growth.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top five exporters account for 30.4% of Sorafenib shipments, consider engaging with a broader range of suppliers to mitigate dependency risks.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance records of potential suppliers, especially those in Hyderabad and Vadodara, to ensure consistent quality and regulatory adherence.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad region to streamline logistics and reduce lead times for international shipments.
- Monitor Regulatory Changes: Stay informed about tax incentives and regulatory developments in regions like Baddi-Nalagarh to capitalize on cost-saving opportunities.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Sorafenib exporters from India
Torrent Pharmaceuticals Ltd — Torrent Pharmaceuticals completes acquisition of JB Chemicals
On January 21, 2026, Torrent Pharmaceuticals Ltd finalized the acquisition of a 46.39% equity stake in JB Chemicals & Pharmaceuticals Ltd from Tau Investment Holdings Pte. Ltd., an affiliate of KKR, for approximately ₹19,500 crore. This transaction positions Torrent as the controlling promoter of JB Pharma. - IMPACT: This acquisition is expected to enhance Torrent's production capabilities and market reach, potentially increasing Sorafenib exports.
Impact: This acquisition is expected to enhance Torrent's production capabilities and market reach, potentially increasing Sorafenib exports.
Torrent Pharmaceuticals Ltd — CCI approves Torrent's acquisition of JB Chemicals
The Competition Commission of India (CCI) approved Torrent Pharmaceuticals Ltd's proposed acquisition of a stake in JB Chemicals and Pharmaceuticals, subject to voluntary modifications offered by the companies. - IMPACT: Regulatory approval facilitates the merger, potentially leading to increased Sorafenib production and exports.
Impact: Regulatory approval facilitates the merger, potentially leading to increased Sorafenib production and exports.
Torrent Pharmaceuticals Ltd — Torrent Pharma announces acquisition of JB Chemicals
Torrent Pharmaceuticals Ltd announced definitive agreements to acquire a majority stake in JB Chemicals & Pharmaceuticals Ltd from KKR at an equity valuation of ₹25,689 crore, followed by a merger of the two entities. - IMPACT: The planned merger is anticipated to strengthen Torrent's market position, potentially boosting Sorafenib exports.
Impact: The planned merger is anticipated to strengthen Torrent's market position, potentially boosting Sorafenib exports.
Common Questions — Sorafenib Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which sorafenib supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, TORRENT PHARMACEUTICALS LTD leads with 12 recorded shipments worth $3.2M. NATCO PHARMA LIMITED (17 shipments) and MEDYRA PHARMACEUTICAL (15 shipments) are also established high-volume exporters.
Q How many sorafenib manufacturers are there in India?
India has 203 active sorafenib exporters with a combined export market of $16.6M across 916 shipments to 98 countries. The top 5 suppliers hold 30.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for sorafenib from India?
Average FOB unit price: $58.93 per unit, ranging from $0.01 to $3266.11. Average shipment value: $18.2K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 203 verified Indian exporters of Sorafenib ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 916 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 98 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
916 Verified Shipments
203 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists